Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

Merck & Co. and Eisai reported mixed results from a late-stage study of the cancer drugs Keytruda and Lenvima in patients with certain types of gastroesophageal cancer.

RAHWAY, N.J. & NUTLEY, N.J., January 24, 2025--Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Business Wire • yesterday Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and ...

Phase II trial evaluating efti in combination with radiotherapy plus KEYTRUDA® (pembrolizumab) in patients with soft tissue sarcoma reaches ...

Prem Watsa is a Canadian billionaire, entrepreneur, and investor often referred to as the Canadian Warren […] RAHWAY, N.J. & NUTLEY, N.J., January 24, 2025--Merck and Eisai Provide Update on ...

RAHWAY, N.J., January 16, 2025--Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Merck and Japan-based Eisai said on Friday a combination of their therapies failed to extend the lives of patients with a ...

Healthcare & Pharmaceuticalscategory Next-gen Novo Nordisk shot shows 22% weight loss in early results 11:43 AM UTC · Updated ago category Opponents of Kennedy's bid for top health post urge ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and Lenvima didn’t exactly go their way. The Keytruda-Lenvima regimen, used on ...